Sign In
Buy MGNX
$4.69
+0.110 (+2.40%)
At Close: Jun 23, 2026
Contact Levi & Korsinsky by September 24, 2024 Deadline to Join Class Action Against MacroGenics, Inc.(MGNX)
08:53am, Sunday, 25'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 25, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws,
Levi & Korsinsky Notifies Shareholders of MacroGenics, Inc.(MGNX) of a Class Action Lawsuit and an Upcoming Deadline
07:00am, Sunday, 25'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 25, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws,
MGNX LAWSUIT ALERT: Levi & Korsinsky Notifies MacroGenics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
07:00am, Sunday, 25'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 25, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws,
Shareholders of MacroGenics, Inc. Should Contact Levi & Korsinsky Before September 24, 2024 to Discuss Your Rights - MGNX
09:01pm, Saturday, 24'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 24, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws,
MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit
01:00pm, Saturday, 24'th Aug 2024
NEW YORK , Aug. 24, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock or sellers of puts of MacroGenics, Inc. (NASDAQ: MGNX) between March 7,
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against MacroGenics, Inc. - MGNX
12:00pm, Saturday, 24'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 24, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against MacroGenics, Inc. ("MacroGenics" or the "Company") (NASDAQ:MGNX). Such investor
A Lawsuit Has Been Filed Against MacroGenics Inc For Securities Fraud And The Schall Law Firm Invites Investors With Losses To Join
11:00am, Saturday, 24'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against MacroGenics, Inc. ("MacroGenics
Investors who lost money on MacroGenics, Inc.(MGNX) should contact Levi & Korsinsky about pending Class Action - MGNX
05:45pm, Friday, 23'rd Aug 2024
NEW YORK, NY / ACCESSWIRE / August 23, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws,
NEW YORK, Aug. 23, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the September 26, 2024 to seek the role of lead plaintiff in a federal securities class action that
NEW YORK, NY / ACCESSWIRE / August 23, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws,
LOS ANGELES, CA / ACCESSWIRE / August 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against MacroGenics, Inc. ("MacroGenics
NEW YORK, NY / ACCESSWIRE / August 23, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws,
RADNOR, PA / ACCESSWIRE / August 23, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United Stat
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics, Inc. Lawsuit - MGNX
08:45am, Friday, 23'rd Aug 2024
NEW YORK, NY / ACCESSWIRE / August 23, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws,
MacroGenics (MGNX) Accused of Misleading Investors Over Cancer Drug Trial – Hagens Berman
08:25am, Friday, 23'rd Aug 2024
MGNX Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, CA / ACCESSWIRE / August 23, 2024 / Hagens Berman urges MacroGenics, Inc. (NASDAQ:MGNX) investors who suffered substantial loss
